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Collaboration, competition and publication in
toxicology: views of British Toxicology Society
members†
Emma S. Walker, a Ruth A. Roberts *b,c and Jason H. Gill d,e
To ascertain attitudes to resourcing, collaboration and publication in toxicology, a survey was developed
and distributed to British Toxicology Society (BTS) members. The survey comprised 14 questions with 5
response options (strongly agree; agree; conﬂicted; disagree; strongly disagree) and a free text box. One
hundred completed surveys were received by the cut-oﬀ date for data analysis. Unsurprisingly, 60% of
participants disagreed or strongly disagreed that toxicology research is adequately funded in the UK; only
12% agreed with this statement. A similar proportion of participants (53%) disagreed with the statement
that funding councils give equal opportunity to toxicology whereas 31% were conﬂicted on this point. An
overwhelming 97% of respondents agreed that collaboration is important in driving toxicology research
whereas only 38% agreed that competition is important. When this question was broadened out beyond
the discipline of toxicology, a similar proﬁle was seen suggesting that participants held similar views on
toxicology versus other types of research. Many respondents were conﬂicted regarding the role of com-
petition both in toxicology and in other research disciplines. Free text comments suggested that some
competition is good to drive quality but can be counterproductive when competing for limited resources.
Most participants were in favour of making toxicology research data openly available (86%) and in favour
of open access publication (89%) although there were reservations about the cost of open access. Many
(60%) thought the current system of peer review is fair but 65% also supported the idea of double-blind
peer review (where both reviewer and author are anonymized). Others suggested a step in the opposite
direction towards increased transparency (revealing and holding reviewers to account) would be prefer-
able. Overall, there was a broad theme in free text responses that the need for experienced toxicologists
has increased at a time when training and investment in the discipline has declined. However, not all
respondents held that view with some noting that toxicology both as a research and as an applied disci-
pline is strong within the UK scientiﬁc community.
Introduction
Controversial topics such as the use of animals in research,
health scares around food contamination or adverse events in
clinical trials have often placed toxicology in the focus of both
scientific and societal concern. Toxicologists are challenged by
the necessity to keep the discipline current, relevant and ethical
amidst the plethora of emerging issues and technologies. We
previously explored the ethical concerns of conflict of interest
(COI), transparency, reproducibility and funding of animal
research and suggested new ways of working for discussion.1
This opinion paper triggered a number of questions and areas
to explore regarding current attitudes to toxicology research in
the UK. In addition to these ethical concerns, many believe that
toxicology as a discipline is under threat from several directions
both in the UK and in Europe. As highlighted in a 2016 letter
from EUROTOX, the European Federation of Toxicology
Societies,2 these threats include reduced resourcing and a
reduction in the number of academic posts and training places.
To address current attitudes of toxicologists to challenges
to their discipline, we developed a survey intended to elicit the
views of current practitioners of the discipline. This larger
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survey was based on the outcome from a pilot survey distribu-
ted to a small group of toxicologists seeking responses to
posed questions but also seeking feedback on process and
survey format (Masters’ Research Project Study conducted by E
Walker; unpublished data). Based on the outcome of this
pilot, a larger survey was developed and distributed to British
Toxicology Society (BTS) members and toxicology conference
participants asking for opinions on resourcing, collaboration,
competition, research infrastructure and peer review. Herein
we present the outcome of this research. Conclusions are
focused on UK toxicology but are clearly relevant to many
aspects of scientific research in the UK and elsewhere.
Experimental
A survey comprising 14 questions (Table 1) was prepared to
explore diﬀerent aspects of attitudes to toxicology funding,
peer review and publication (see ESI 1† for full survey format).
In the pilot survey, 7 questions on toxicology research were
posed to 12 volunteers seeking responses to the questions but
also feedback on survey format. Based on the comments
received, several modifications were made to the questions
posed and to the survey format including the addition of the
open text box so respondents could provide explanations for
their answers.
The survey was accompanied by a participants’ information
sheet (see ESI 2†) that explained the purpose of the study and
information around data protection and confidentiality. The
survey and participants’ information sheet were reviewed and
approved by the Executive Committee of the BTS for distri-
bution to BTS members and BTS conference participants. The
survey was distributed by the BTS Secretariat via a web link.
Anonymized responses were collated into an excel spread-
sheet for analysis and review. At the date preset for the close of
the survey, one hundred responses had been received. Thus,
data are presented as actual numbers of respondents but can
also be quoted as percent response. Since the survey was set
up as an exploratory study the data are presented as a descrip-
tive analysis of results. Not all data add up to the 100 respon-
dents since there were some non-responders (0–4 people) for
some questions. Although data were anonymized, each respon-
dent had a ‘respondent number’ preserved across all questions
allowing for an analysis of internal pairings of answers.
Raw data, plots and pivot tables are available in ESI 3.†
Results and discussion
Views on resourcing in toxicology (Q1 and Q2)
Only 12% of respondents agreed that toxicology research is
adequately funded in the UK (Fig. 1). The majority of respon-
Table 1 Questions by number and response options
Number Question Response options
1 I believe toxicology research is adequately resourced in the UK Strongly agree
2 When compared to other disciplines, I believe the research funding councils and other
funding bodies provide equality of opportunity to facilitate toxicology research
Agree
3 I believe collaboration to be important in driving toxicology research in the UK Conflicted
4 When compared to other disciplines, I believe collaboration to be especially
important in driving toxicology research
Disagree
5 I believe competition to be important in driving toxicology research in the UK Strongly disagree
6 When compared to other disciplines, I believe competition to be especially
important in driving toxicology research
7 I believe there is a good infrastructure to support research between academia,
industry and the regulatory authorities
8 I believe making toxicology research data openly available with as few restrictions as possible in a
timely and responsible manner would improve the impact and eﬃciency of toxicological research
9 When reading research publications, I consider whether there is a conflict of interest when assessing
the validity of research
10 I believe the current system of peer review for research outputs is a fair and appropriate system
11 When peer reviewing research publications, I consider whether there is a conflict of interest when
assessing the validity of research
12 I believe reviewers are often not suﬃciently trained to adequately and fairly judge the merit,
quality and impact of toxicology research
13 I believe double-blind peer review, where both reviewer and author are anonymised, is a good idea
14a I believe open access publication, where articles are available free at source, is a good idea
14b Have you published research outputs using an open access route in the last two years? Yes
No
14c If so, how was the cost for publication supported? Institute or employer
Collaborator or industry
sponsor
Competitive research award
Competitive research award
(co-author)
Funded personally
Not applicable
Other (free text)
Toxicology Research Viewpoint
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dents (60%) disagreed or strongly disagreed with this state-
ment. With reference to research councils and other bodies
providing equality of opportunity to toxicology research, only
13% of respondents agreed this was true (Fig. 1) with 52% dis-
agreeing/strongly disagreeing with this statement. Around 30%
of respondents were conflicted in their responses to these two
questions. It’s notable that the two profiles for Q1 and Q2 are
very similar which could suggest that individual participants
responded similarly to the two questions. However, a pairing
analysis suggested this wasn’t necessarily the case; the highest
concordance between the two questions was in ‘disagree’ yet
only 15 of the 41 participants who disagreed with Q1 also dis-
agreed with Q2. This suggests, as aﬃrmed by the free text
answers, that equality of opportunity is not the only issue in
funding. In this context, respondents highlighted both Tox213
and ToxCast4 as great examples of investment in toxicology by
the US government, delivering a transformation in the profile
of toxicology.
The disagree/strongly disagree category for Q1/Q2 yielded
more free text answers than any other questions in the survey.
Comments fell broadly into three categories (Table 2) around
reductions in training/resourcing/career guidance, lack of
appreciation of the value of the discipline and a third category
of relatively emotive statements. One comment summarized
an overall view expressed by those that disagreed/strongly dis-
agreed that toxicology is adequately resourced: ‘Academic
centres have reduced, government spending over a long period has
been minimal, pharmaceutical companies have relocated or con-
tracted, CRO’s do not have development of the science at their core
purpose’. Several respondents highlighted that many pharma-
ceutical companies have contracted in the UK. While this may
be true, the Association of the British Pharmaceutical Industry
(ABPI) data5 shows that the number of pharmaceutical enter-
prises in the UK rose steadily between 2012 and 2015 (the last
year in the survey). ABPI data also show that the number of
people employed has stayed relatively constant at around
60–65 thousand employees over the last decade since 2009.5 A
possible explanation of this apparent discrepancy in views is
that while large pharma is contracting, the UK small and
medium enterprise (SME) biotech sector is booming with 2019
figures showing a 40% increase in investment.6
Overall, there was a broad theme that the need for experi-
enced toxicologists has increased at a time when training and
investment in the discipline has declined. Also notable in the
free text comments was a concern around sustainability and a
perception that toxicology in the US is still well resourced as
summarized by this participant: ‘Although there is a fair amount
of toxicology research underway in the UK it is clearly not as well-
resourced as toxicology research elsewhere in the world such as
the USA’. Also notable was the perspective from one early
career scientist who stated that ‘As a student hoping to enroll on
a toxicology associated PhD, my experience in looking for such
opportunities suggests that projects of a toxicological nature are
far less common than those in alternative biological/pharma-
ceutical areas’.
Of the 12 participants that agreed or strongly agreed that
toxicology was adequately resourced in the UK, several pro-
vided free text comments primarily on two themes. Firstly, that
hazard and risk assessments are adequately done in the UK.
Secondly, that toxicology is a multidisciplinary science and
therefore training in other disciplines feeds the pool of toxicol-
Fig. 1 Views on resourcing in toxicology. Responses to two questions
are shown: “I believe toxicology research is adequately resourced in the
UK” (blue) and “When compared to other disciplines, I believe the
research funding councils and other funding bodies provide equality of
opportunity to facilitate toxicology research” (grey).
Table 2 Free text comments to question 1
Theme Overall point Example answers
Disagree/strongly
disagree
Lack of appreciation of the value of
the discipline
It is virtually impossible to obtain research council funding for toxicology-based
research they are just not interested
Not enough input
Not enough being done to drive the discipline forward
It’s like the forgotten science, despite being front and central to many areas
Training, research and career
development much reduced
As a early career researcher, I have noticed that any toxicology-related education or
career advice have been eﬀectively absent throughout my undergraduate and
postgraduate studies
Not promoted as an eﬀective career
No resources for research
Emotive statements We are screaming out for studies to be done
Why would drug companies want to identify problems!
Viewpoint Toxicology Research
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ogists. This second theme touches on a concept explored in
the initial opinion article1 where we proposed that toxicology
must be willing to redefine its boundaries as a discipline and
draw strength and diversity from other sciences. One impor-
tant discussion point regarding resourcing of toxicology is the
distinction between education and training. In general terms,
training refers to imparting a special skill or behavior to a
person and is often delivered ‘on the job’ and/or in applied
training courses. It is not the same as education, which is
usually delivered by an institution with the aim of developing
a sense of judgment and reasoning that can be applied to any
topic or problem. Thus, scientists who have received an edu-
cation in topics such as biochemistry, pharmacology, medi-
cine, veterinary sciences, physiology and mathematics are all
great potential toxicologists, but a training course coupled
with significant ‘on the job’ experience is required to trans-
form such individuals into toxicologists. Thus, postgraduate
training courses in toxicology should be supported and
expanded.
Views on collaboration and competition in toxicology (Q3–6)
Overall, respondents were enthusiastic about collaboration. An
overwhelming 97% of respondents agreed that collaboration is
important in driving toxicology research in the UK (Q3;
Fig. 2A). Notably, no respondent disagreed with this statement.
This is not surprising since it is diﬃcult to think of a down-
side to collaboration as a concept. When this question was
broadened out beyond the discipline of toxicology (Q4), most
participants disagreed that collaboration is uniquely important
in driving toxicology research. Thus, participants were in
favour of collaboration in toxicology and in other disciplines.
However, opinions around competition were more conflicted.
When similar questions were asked regarding the role of com-
petition in driving toxicology research (Qs 5 & 6), a very
diﬀerent profile emerged; roughly equal numbers of respon-
dents agreed/strongly agreed (38) versus disagreeing/disagree-
ing (30) with the statement that competition is important in
driving toxicology research (Fig. 2B). When the question on
competition was broadened out beyond the discipline of toxi-
cology, a similar profile was seen, suggesting that participants
held similar views on the role of competition in toxicology
versus other types of research.
A pairing analysis (Table 3) produced a notable pattern in
concordance around collaboration: of the 71 participants who
strongly agreed with Q3 (collaboration is important in toxi-
cology), 42 of them also strongly agreed with Q4 (collaboration
is uniquely important in toxicology). Looking at this the other
way around, 92% (46/50) of those who strongly agreed with Q4
also strongly agreed with Q3.
Questions (5 & 6) regarding competition in toxicology and
other disciplines produced a high number of conflicted
responses (32 and 37, respectively). A pairing analysis showed
that 26 respondents were conflicted over both questions. The
overall theme of the ‘conflicted’ free text comments on the role
of competition in driving research was that some competition
is good to drive quality but that it can be counterproductive
when groups are competing for limited resources. This raises
an interesting point in that competition is regarded as intrin-
sic to the conduct of research in any discipline, including toxi-
cology. For example, researchers compete for grant funding,
journal space, training positions and jobs; this is generally
regarded as an important step in ensuring quality. However, if
competition is taken to extremes it can prevent eﬀective collab-
oration; these aspects of toxicology (when to compete and
when to collaborate) are more about scientists possessing the
interpersonal skills to ensure appropriate and constructive
behaviour rather than about the scientific discipline per se. In
this regard, perhaps ‘responsible competition’ should be high-
lighted in degree courses and career and professional training
programmes.
To understand if there is a relationship between concern
around resources and concern around the role of competition,
a pairing analysis was conducted to see how those that dis-
agreed with Q1 (toxicology research Is adequately funded)
Fig. 2 Views on collaboration and competition in toxicology. (A)
Responses to two questions are shown: “I believe collaboration to be
important in driving toxicology research in the UK” (blue) and “When
compared to other disciplines, I believe collaboration to be especially
important in driving toxicology research” (grey). (B) Responses to two
questions are shown: “I believe competition to be important in driving
toxicology research in the UK” (blue) and “When compared to other dis-
ciplines, I believe competition to be especially important in driving toxi-
cology research” (grey).
Toxicology Research Viewpoint
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responded to Q5. Of the 41 respondents who disagreed that
toxicology is adequately resourced, 17 of them agreed that
competition plays a positive role in driving toxicology research
and 8 of them were conflicted on this statement. Thus, it
would seem that concern over adequate resourcing is not the
main driver for a dislike of competition among some
participants.
Views on research infrastructure (Q7)
Only 25% of participants agreed or strongly agreed that there
is a good infrastructure to support research between academia,
industry and the regulatory authorities (Fig. 3). Many more
(43) disagreed or strongly disagreed with this statement.
Again, there were many respondents (32) that reported being
conflicted on this question. Free text reasons for the conflict
fell into three broad categories (Table 4): room for improve-
ment, role of the individual and COI. Under ‘Room for
improvement’, participants generally highlighted positive
aspects such as collaboration between academia and industry
that they would like to see more of. Under ‘Role of the individ-
ual’, there was a lot of emphasis on interpersonal skills which
echoes comments made earlier around ‘responsible compe-
tition’. One respondent specifically mentioned the positive
role played by the BTS in supporting research infrastructure.
This question highlights an opportunity to improve support
and infrastructure in toxicology.
Views on open access (Q8 & 14a)
Most participants (86%) were strongly in favour of making toxi-
cology research data openly available (Fig. 4) with only 2 dis-
agreeing that this was a good idea. Similarly, most participants
were strongly in favour of open access publication with only
3% disagreeing that this is a good idea. It’s notable that the
profiles of responses to these two questions on open access are
largely similar overall with 41% of respondents agreeing with
both statements (see Fig. 4) and with good internal concor-
dance in response. For example, of the ‘strongly agree’ for
question 8 (45 participants), 33 (73%) of these individuals also
strongly agreed with question 14a. These two questions were
generally met with decisive opinions in respondents, with few
participants answering ‘conflicted’ on question 8/14a (12/8
participants, respectively). Only one participant reported
feeling conflicted on both of these statements suggesting that
views on open access were quite clear amongst the
respondents.
Some of the comments regarding open access were as
expected with strong support for scientists to access useful
information. Others commented that data sharing can help
avoid duplication of animal experimentation. However, there
were some potentially controversial free text comments largely
from those who agreed that it was a good idea; specifically,
one participant stated that ‘Most publishers bring very little
value added to the table, and are exploiting the voluntary eﬀorts
of others to make large profits’ and another that ‘…publishing
houses are taking the scientific community for a ride. You don’t
even get access to your work unless you have subscription or access
to one’. These opinions reflect a recent trend in pushing back
on publishing strategies as illustrated by the University of
California which has decided not to renew its journal subscrip-
tions with Elsevier in a disagreement over ‘the rapidly escalat-
ing costs associated with for-profit journals’.7
Views on conflict of interest (Q9 & 11)
Conflict of interest (COI) emerged as an important consider-
ation for the survey respondents; the majority agreed or
strongly agreed (69%) that they consider whether there is a
Table 3 Concordance in responses between Q3 and Q4. Paired answers are highlighted in grey
Fig. 3 Views on research support infrastructure. Responses to one
question are shown “I believe believe there is a good infrastructure to
support research between academia, industry and the regulatory
authorities”.
Viewpoint Toxicology Research
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COI when reading research publications (Fig. 5). Only 17% dis-
agreed with the statement. Similarly, most participants agreed
or strongly agreed (68%) that they consider whether there is a
COI when reviewing research publications (Fig. 5) with only
3% disagreeing with this statement. It’s notable that the pro-
files of responses to the two COI questions are largely similar
overall (see Fig. 5) and there was also good internal concor-
dance in response. For example, of the ‘strongly agree’ for
question 9 (49 participants), 31 (63%) of these individuals also
strongly agreed with question 11.
Free text comments oﬀered more detail on opinions on
COI. Several participants commented that considering COI
was a very important issue and was ‘self-evident’. Others stated
that they would decline to review if there was COI. There were
also several free text comments to clarify what COI meant to
individual participants: ‘…only if it is a REAL conflict of interest
rather than inferred just because of employer or sources of grant
funding’. Rather than decline to review, others suggested that if
they perceived COI then they would ‘be more insistent on
approaching every sentence with the mindset of an auditor – Can
the statement be fully supported backed up by data that is pre-
sented if it can’t be supported, are more data required or should
the statement be edited or removed?’ The topic of COI came up
also in the free text responses to Question 7 on research infra-
structure (Table 4). Specifically, participants commented that
real or perceived COI could be a block to the creation and
Table 4 Free text responses to question 7 (research infrastructure)
Theme Overall point Example answers
Conflicted Mixed – room for
improvement
The collaboration is present at the BTS congress and other meetings. Otherwise interactions can be
limited especially with regulatory agencies
There are good industry/academic links, but we should harness these links more broadly rather than
company by company
There could be more done to support this
In some instances I agree, however more collaboration between more academic departments and
institutes would be welcome instead of just a few working with industry
Yes and No – my issue is that on the whole regulatory authorities do a good job, but they are often diﬃcult
to deal with and can be fairly unhelpful. It should be more a collaborative approach
It’s about individuals I think it depends on the individual authorities/institutions
I have experience of when the diﬀerent areas have worked well together. But this has been down to the
good will of the individuals concerned, rather than anything that stems from government funded actions
Where it works well it’s about networks & personal relationships rather than infrastructure – depends on
individuals’ commitment to making something happen …
Real or perceived COI Mixed feelings here. On the one hand academic institutions are forced to cooperate with other partners
due to declining funding from government bodies. On the other hand society is suspicious to this
cooperation. Moreover, many regulatory authorities want to be “independent” and not very keen on
cooperation
For some collaborations this exists but the perception of the conflicting interests of these 3 organisations
often prevents eﬀective collaboration
Fig. 4 Views on open access. Responses to two questions are shown “I
believe making toxicology research data openly available with as few
restrictions as possible in a timely and responsible manner would
improve the impact and eﬃciency of toxicological research” (blue) and “I
believe open access publication, where articles are available free at
source, is a good idea” (grey).
Fig. 5 Views on conﬂict of interest. Responses to two questions are
shown “When reading research publications, I consider whether there is
a conﬂict of interest when assessing the validity of research” (blue) and
“When peer reviewing research publications, I consider whether there is
a conﬂict of interest when assessing the validity of research” (grey).
Toxicology Research Viewpoint
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maintenance of the eﬀective research infrastructure networks
needed to drive a multidisciplinary subject such as toxicology.
There were a few participants that were conflicted on ques-
tions 9 and 11, but only 3 participants reported being con-
flicted on both of these statements. Most of the free text com-
ments on ‘conflicted’ for questions 9 and 11 were around the
participant feeling unable to comment due to lack of knowl-
edge of current systems.
The data and freetext responses show that COI was clearly
an issue of concern amongst survey participants, with several
highlighting the need to distinguish between real and per-
ceived COI. COI was helpfully defined in 2017 as ‘…a set of cir-
cumstances that creates a risk that professional judgement or
actions regarding a primary interest will be unduly influenced
by a secondary interest’.8 Clearly, circumstances that create a
real risk of COI are to be avoided. However, what is meant by
perceived COI? It was pointed out more than a decade ago that
COI is being used in gamesmanship where, for example,
‘strong assertions of conflict of interest are used to justify particu-
lar points of view’.9 This challenge still persists today with
ongoing attention on COI and some unfortunate consequences
such as the exclusion of industry scientists from governmental
panels and review committees.8
Views on peer review (Q10, 12 & 13)
Overall, the survey respondents favoured the current peer
review system with the majority (60%) of respondents agreeing
or strongly agreeing that the current system of peer review is
fair with only 7% disagreeing or strongly disagreeing with this
statement (Fig. 6). Interestingly, 65% also agreed or strongly
agreed that double blind peer review (where both reviewer and
author are anonymized) is a good idea with only 11% disagree-
ing/strongly disagreeing. Since most journals currently do not
use double blind peer review, these answers could be hard to
interpret. However, the free text responses to agree/strongly
agree with Q13 oﬀer some explanation; broadly speaking, par-
ticipants support the need for peer review and support the
current system but feel that double blind review is ‘an interest-
ing idea’ or ‘worth a go’. Looking at internal data comparisons,
of the 56 participants that agreed that the current system of
peer review is fair, 10 were conflicted and 6 disagreed/strongly
disagreed with double blind peer review.
There were some interesting points raised in the free text
from those both in favour of and against double blind peer
review (Table 5). Many disputed the value and feasibility;
others suggested that a step in the opposite direction towards
increased transparency (revealing and holding reviewers to
account) would be preferable.
In this survey we only asked about the currently prevalent
system of peer review (where reviewers are anonymous) and
attitudes to double blind peer review. However, there are other
systems that can be considered such as “Open Peer Review”
(OPR) and triple blind peer review (where authors and their
institutions are reciprocally anonymous to reviewers and
editors).10 In their review, Tennant et al.10 present a detailed
analysis to consider the pros and cons of these various
systems.
Some participants agreed (30) or strongly agreed (7) that
reviewers are not suﬃciently trained to judge the merit, quality
and impact of toxicology research. However, 21% disagreed/
strongly disagreed with this statement. A large number (41%)
were conflicted on this point, the highest number of conflicted
answers for any of the questions in the survey. There were very
few free text answers oﬀered by those who disagreed with this
question. However, those who agreed/strongly agreed (that
reviewers are not suﬃciently trained) oﬀered free text answers
mainly drawn from negative personal experience with com-
ments such as ‘this is very clear from some of the referees’ com-
ments I received in the past’ and ‘Often they seem to miss point’.
Many of the conflicted respondents oﬀered similar views that
were well summarized by one participant; ‘It is mixed. Some are
excellent. Some very dismissive and some simply do not under-
stand the science’.
It may be useful to follow this survey with a more detailed
analysis of views of the BTS towards peer review. There is also
the opportunity to oﬀer training to BTS members and other
toxicologists based around the 6-red flags rules described by
Begley.11 These flags include such fundamental issues as inap-
propriate reagents, lack of reproducibility and absence of con-
trols. Steps have been proposed to overcome this for toxicology
as a discipline;12 the BTS could play a role in delivering an
integrated and unified approach to address COI, peer review
and unreproducible data across all basic and applied pharma-
cology and toxicology.1
Other observations
Several other themes emerged in the free text comments
oﬀered by participants, mainly by those who were concerned
regarding declining resourcing of toxicology and the overall
Fig. 6 Views on peer review. Responses to three questions are shown “I
believe the current system of peer review for research outputs is a fair
and appropriate system” (blue), “I believe reviewers are often not
suﬃciently trained to adequately and fairly judge the merit, quality and
impact of toxicology research” (grey) and “I believe double-blind peer
review, where both reviewer and author are anonymised, is a good idea”
(green).
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sustainability of the discipline. The BTS was mentioned as a
key arena for collaboration but with the caveat that collabor-
ation is optional and not to be mandated.
ITTP (MRC Integrative Toxicology Training Partnership)13
was also mentioned by several participants as a great scheme,
typified by the following comment: ‘It took huge eﬀort to get the
ITTP programme to work – but it is very limited in comparison to
other sectors and review panels rarely have toxicologists evaluat-
ing the merit of applications for funding’. Two other key themes
were: 1. the decline of Centres of Excellence for Toxicology
Research such as Central Toxicology Laboratory and Bibra
which were instrumental in many aspects such as driving
research, training and collaboration and 2. The decline of toxi-
cology training centres as illustrated by this quote: ‘There are
not enough training locations for Tox in the UK. Only Birmingham
oﬀers a full-time and part-time MSc course. The community is still
reeling from the closure of the Surrey course’.
Limitations of the survey and its interpretation
There are several limitations to this survey and its interpret-
ation. Firstly, the survey was set up as an exploratory study; as
such the data are presented as a descriptive analysis of results.
Secondly, the sampling strategy is inherently biased since it
seeks the views just of BTS members without a suitable refer-
ence group (with and/or without scientific expertise) – thus it
is not possible to determine the degree of ‘expert bias’ in the
data. Thirdly, only a limited proportion of BTS members
responded; it is possible that those that did respond chose to
do so since they hold strong views on the survey topics and as
such may not be representative of the wider views of the BTS
membership.
Conclusions
This report assessed the attitudes of toxicologists to challenges
in their discipline. The results of the survey suggest that there
is a persistent concern around resourcing, training and sus-
tainability for the discipline of toxicology within the UK com-
munity. There is a recognition that much can be achieved with
limited resources via collaboration especially across the sectors
of academia, industry and government but that perceived COI
can sometimes be a barrier to this collaboration. Interestingly,
there were split views on the role of competition since it can
drive innovation but can also be counterproductive if scientists
are competing for limited resources. In this respect, there may
be a role for the BTS in propagating ‘responsible competition’
where competition ensures quality but is not a barrier to col-
laboration. The survey also suggests that we need to take a
fresh look at peer review of both grants and papers and con-
sider either double blind peer review or more interestingly, a
move towards more transparency where reviewers are no
longer anonymous. Also relevant is to drive greater awareness
of the 6-red flags;11 this would ensure that all scientists review-
ing toxicology data either in the context of grant proposals or
papers could avoid common pitfalls. Other concerns emerged
on the cost of open access and some concern over who pays
these charges. Overall, there was a broad theme in free text
responses that the need for experienced toxicologists has
increased at a time when training and investment in the disci-
pline has declined. However, not all respondents held that
view with some noting that toxicology both as a research and
as an applied discipline is strong within the UK scientific com-
munity. An informative area for future research would be to
explore how views diﬀer across public versus the private sector
and also if there are diﬀerences in views between early and
later career toxicologists.
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Table 5 Free text responses to question 12 (double blind peer review)
In favour Against
Anonymity Gives more opportunity to unknown and up-and-
coming groups
It’s good to know the group’s history and reputation
It doesn’t take much to work out who the authors are and where they are from
I am happy to be identified as a reviewer and would prefer that rather than
blinding the authors
Process Not sure how this would work It’s too complex
Already too time consuming – this would make it worse
Is this even feasible?
Value It seems fairer good to decide purely based on what
is presented
I can’t see how this would help
Is there a problem to fix?
Toxicology Research Viewpoint
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